Literature DB >> 15129402

Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up.

Raoul H Engelbert1, Cuno S Uiterwaal, Willem-Jan Gerver, Jan-Jaap van der Net, Hans E Pruijs, Paul J Helders.   

Abstract

OBJECTIVES: To study (1). changes in anthropometrics, joint range of motion (ROM), muscle strength, functional ability, caregiver assistance, and level of ambulation in children with osteogenesis imperfecta (OI) and (2). the prediction of clinical characteristics at the level of ambulation at follow-up and the prediction of clinical characteristics on progression or regression at the level of ambulation over time.
DESIGN: Prospective study with follow-up of 4 years.
SETTING: A children's hospital that serves a nationwide center for treatment and research in children with OI in the Netherlands. PARTICIPANTS: At follow-up, 49 children (24 boys, 25 girls; mean age +/- standard deviation, 11.3+/-3.8y; range, 5.2-19.4y) participated.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Anthropometry, joint ROM, muscle strength, fracture frequency, intramedullary rodding, level of ambulation, functional ability, and caregiver assistance.
RESULTS: In type I OI, total joint ROM decreased significantly over time, especially in the lower extremities, with a significant decrease in generalized joint hypermobility according to Bulbena (median start, 7.5; interquartile range [IQR], 4-9; median end, 6; IQR, 2-7; P<.001). In types III and IV, a severe decrease in total joint ROM was present without significant changes over time. No significant changes in total muscle strength (upper or lower extremities) in the different types of OI were measured at follow-up. In OI type I, a significant increase in self-care (P=.003) and social function (P=.008) was measured; in type III, a significant increase in self-care (P=.003), mobility (P=.004), and social function (P=.005) was measured, with a significant decrease in parental assistance in self-care (P=.02) and mobility (P=.005). In type IV, a significant increase was observed in the self-care (P=.01) and social function domains (P=.02). Type of OI (regression coefficient=-1.0; 95% confidence interval [CI], -1.64 to -0.47) and total muscle strength were the only significant predictors for level of ambulation (regression coefficient=.01; 95% CI,.17-.32). Body weight was significantly lower in the group that progressed in level of ambulation (P=.03), whereas children with a decline in level of ambulation had significantly higher body weight (P=.05).
CONCLUSIONS: Ours is the first study with a long-term follow-up that provides information concerning the natural course of developmental outcome parameters of OI in childhood. Joint ROM and muscle strength did not change significantly over time, possibly because of the biomechanical skeletal properties of the different OI types. Functional ability improved significantly over time, but, especially in types III and IV, did not reach normative values, possibly because of a plateau phase in functional ability. Knowledge of the natural course of the disease is essential to interpret the results from intervention studies.

Entities:  

Mesh:

Year:  2004        PMID: 15129402     DOI: 10.1016/j.apmr.2003.08.085

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  26 in total

1.  Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year.

Authors:  Joanne Ruck; Noémi Dahan-Oliel; Kathleen Montpetit; Frank Rauch; François Fassier
Journal:  J Child Orthop       Date:  2011-05-08       Impact factor: 1.548

2.  Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.

Authors:  Keren Machol; Trevor D Hadley; Jake Schmidt; David Cuthbertson; Henri Traboulsi; Rodrigo C Silva; Chloe Citron; Sobiah Khan; Kate Citron; Erin Carter; Kenneth Brookler; Jay R Shapiro; Robert D Steiner; Peter H Byers; Francis H Glorieux; Michaela Durigova; Peter Smith; Michael B Bober; Vernon R Sutton; Brendan H Lee; Sandesh C S Nagamani; Cathleen Raggio
Journal:  Am J Med Genet A       Date:  2019-12-26       Impact factor: 2.802

3.  Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.

Authors:  Y Song; D Zhao; L Li; F Lv; O Wang; Y Jiang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-12-19       Impact factor: 4.507

Review 4.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

Review 5.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 6.  The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review.

Authors:  Argerie Tsimicalis; Gabrielle Denis-Larocque; Alisha Michalovic; Carolann Lepage; Karl Williams; Tian-Ran Yao; Telma Palomo; Noemi Dahan-Oliel; Sylvie Le May; Frank Rauch
Journal:  Qual Life Res       Date:  2016-02-19       Impact factor: 4.147

7.  Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial.

Authors:  Dieke H J Kok; Ralph J B Sakkers; Arieke J Janse; Hans E H Pruijs; Ab J Verbout; Rene M Castelein; Raoul H H Engelbert
Journal:  Eur J Pediatr       Date:  2007-02-17       Impact factor: 3.183

8.  Modified Sofield-Millar operation: less invasive surgery of lower limbs in osteogenesis imperfecta.

Authors:  Mazen Abulsaad; Ashraf Abdelrahman
Journal:  Int Orthop       Date:  2008-02-19       Impact factor: 3.075

9.  Conservative versus surgical treatment of osteogenesis imperfecta: a retrospective analysis of 29 patients.

Authors:  Eugenio Chiarello; Davide Donati; Giuseppe Tedesco; Luca Cevolani; Tommaso Frisoni; Matteo Cadossi; Martha Hoque; Benedetta Spazzoli; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

10.  Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.

Authors:  Hongqing Du; Melissa S Cline; Robert J Osborne; Daniel L Tuttle; Tyson A Clark; John Paul Donohue; Megan P Hall; Lily Shiue; Maurice S Swanson; Charles A Thornton; Manuel Ares
Journal:  Nat Struct Mol Biol       Date:  2010-01-24       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.